Temporal Profile of Care Following Mild Traumatic Brain Injury: Predictors of Hospital Admission, Follow-up Referral and Six-month Outcome
Overview
Authors
Affiliations
Objective: To investigate the clinical management and medical follow-up of patients with mild traumatic brain injury (mTBI) presenting to emergency departments (EDs).
Methods: Overall, 168 adult patients with mTBI from the prospective, multicentre Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Pilot study with Glasgow Coma Scale (GCS) 13-15, no polytrauma and alive at six months were included. Predictors for hospital admission, three-month follow-up referral and six-month functional disability (Glasgow Outcome Scale-Extended (GOSE) ≤ 6) were analysed using multivariable regression.
Results: Overall, 48% were admitted to hospital, 22% received three-month referral and 27% reported six-month functional disability. Intracranial pathology on ED head computed tomography (multivariable odds ratio (OR) = 81.08, 95% confidence interval (CI) [10.28-639.36]) and amnesia (>30-minutes: OR = 5.27 [1.75-15.87]; unknown duration: OR = 4.43 [1.26-15.62]) predicted hospital admission. Older age (per-year OR = 1.03 [1.01-1.05]) predicted three-month referral, while part-time/unemployment predicted lack of referral (OR = 0.17 [0.06-0.50]). GCS < 15 (OR = 2.46 [1.05-5.78]) and prior history of seizures (OR = 3.62 [1.21-10.89]) predicted six-month functional disability, while increased education (per-year OR = 0.86 [0.76-0.97]) was protective.
Conclusions: Clinical factors modulate triage to admission, while demographic/socioeconomic elements modulate follow-up care acquisition; six-month functional disability associates with both clinical and demographic/socioeconomic variables. Improving triage to acute and outpatient care requires further investigation to optimize resource allocation and outcome after mTBI. ClinicalTrials.gov registration: NCT01565551.
Shafique M, Mustafa M, Kumar A, Iqbal J, Haseeb A, Rahman H Asian J Neurosurg. 2025; 20(1):20-33.
PMID: 40041596 PMC: 11875712. DOI: 10.1055/s-0044-1800952.
Dillan M, Piktel J, Perzynski A, Roach M, Curtis K, Tarabichi Y Heliyon. 2025; 11(3):e42230.
PMID: 39944323 PMC: 11815941. DOI: 10.1016/j.heliyon.2025.e42230.
Emerging Trends: Neurofilament Biomarkers in Precision Neurology.
Sharma P, Giri A, Tripathi P Neurochem Res. 2024; 49(12):3208-3225.
PMID: 39347854 DOI: 10.1007/s11064-024-04244-3.
Bryant A, McCrea M, Nelson L Neurotrauma Rep. 2021; 2(1):363-369.
PMID: 34901936 PMC: 8655808. DOI: 10.1089/neur.2021.0012.
Epidemiology of Chronic Effects of Traumatic Brain Injury.
Haarbauer-Krupa J, Pugh M, Prager E, Harmon N, Wolfe J, Yaffe K J Neurotrauma. 2021; 38(23):3235-3247.
PMID: 33947273 PMC: 9122127. DOI: 10.1089/neu.2021.0062.